Medical Xpress November 12, 2024
Researchers from the Data Science and Artificial Intelligence Institute (DATAI) at the University of Navarra have developed artificial intelligence (AI) models to personalize immune therapies for oncology patients.
The study is published in the journal Journal for ImmunoTherapy of Cancer.
The analysis used data from more than 3,000 patients with lung and urothelial cancer (the third and sixth most frequently diagnosed cancers in the United States in 2024, according to the National Cancer Institute). By employing machine learning models, the researchers identified novel genetic signatures specific to each stage of the disease, and created the “IFIT score,” a system that will help personalize the immunotherapy treatment, improving its effectiveness.
The “IFIT score” is a measure or an index of the...
Today's Sponsors
Today's Sponsor